RE:RE:Market reacting to the great presentation!Even if that’s the case, look at CytoDyn. They were on the Wall Street Reporter’s presentation with NexTech back on March 19. Given their promising successful trials to create a vaccine for COVID-19, have you seen their recent stock price? It jumped from $0.94 USD on March 26 to a high of $3.39 USD today!
I understand that the market outlook is currently bleak and risky, even in traditional blue-chip stocks, but consider the success that other companies are able to achieve during these tumultuous times. Continued NR’s and presentations during this time are a good thing, imo. NexTech is well positioned and offers a great opportunity for investors! The time to buy is now! GLTA